COX4-1 promotes mitochondrial supercomplex assembly and limits reactive oxide species production in radioresistant GBM

Authors:

Claudia R. Oliva1, Md Yousuf Ali1,2, Susanne Flor1 and Corinne E. Griguer1

Affiliations:

1 Free Radical & Radiation Biology Program, Department of Radiation Oncology, The University of Iowa, Iowa City, IA 52242.

2 Interdisciplinary Graduate Program in Human Toxicology, The University of Iowa, Iowa City, IA 52242.

Keywords: 

supercomplexes, cytochrome c oxidase, radioresistance, GBM, superoxide, COX4, mitochondria.

Abbreviations:

AA – antimycin A,

CcO – cytochrome c oxidase,

FCCP – p-trifluoromethoxyphenylhydrazone,

GBM – glioblastoma,

IGA – in-gel activity,

MID – mean inactivation dose,

OCR – oxygen consumption rate,

OS – overall survival,

OXPHOS – oxidative phosphorylation,

SC – supercomplex,

ROS – reactive oxygen species.

Corresponding Author(s):

Corinne E. Griguer, 375 Newton Rd, 4032 MERF, Iowa City, 52242, Iowa, USA; Phone 319-384-4754; FAX 319-335-8039; corinne-griguer@uiowa.edu

Conflict of interest statement:

The authors declare that no competing interests exist.

Please cite this article as:

Claudia R. Oliva, Md Yousuf Ali, Susanne Flor and Corinne E. Gri-guer (2022). COX4-1 promotes mitochondrial super-complex assembly and limits reactive oxide species production in radioresistant GBM. Cell Stress 6(4): 45-60. doi: 10.15698/cst2022.04.266

© 2022 Oliva et al. This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduc-tion in any medium, provided the original author and source are acknowledged.

Abstract:

Glioblastoma (GBM) is a fatal disease with recurrences often associated with radioresistance. Although often effective at treating newly diagnosed GBM, increasing evidence suggests that radiotherapy-induced alterations in tumor metabolism promote GBM recurrence and aggressiveness. Using isogenic radiosensitive and radioresistant GBM cell lines and patient-derived xenolines, we found that acquired radioresistance is associated with a shift from a glycolytic metabolism to a more oxidative metabolism marked by a substantial increase in the activity of the mitochondrial respiratory chain complex cytochrome c oxidase (CcO). This elevated CcO activity was associated with a switch in the isoform expression of the CcO regulatory subunit COX4, from COX4-2 to COX4-1, assembly of CcO-containing mitochondrial supercomplexes (SCs), and reduced superoxide (O2●-) production. Overexpression of COX4-1 in the radiosensitive cells was sufficient to promote the switch from glycolytic to oxidative metabolism and the incorporation of CcO into SCs, with a concomitant reduction in O2●- production. Conversely, silencing of COX4-1 expression in normally radioresistant cells reduced CcO activity, promoted the disassembly of mitochondrial SCs, and increased O2●- production. Additionally, gain or loss of COX4-1 expression was sufficient to induce the radioresistant or radiosensitive phenotype, respectively. Our results demonstrate that COX4-1 promotes SC assembly in GBM cells, and SC assembly may in turn regulate the production of reactive oxygen species and thus the acquisition of radioresistance in GBM.